Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'D-2-DOPAMINE RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 358 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kapp, OH; Siemion, J; Kuo, J; Johnson, BA; Shankaran, V; Reba, RC; Mukherjee, J
      Comparison of the interaction of dopamine and high affinity positron emission tomography radiotracer fallypride with the dopamine D-2 receptor: a molecular modeling study

      JOURNAL OF MOLECULAR MODELING
    2. Gimenez-Llort, L; Ahlbom, E; Dare, E; Vahter, M; Ogren, SO; Ceccatelli, S
      Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects

      ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    3. Shen, DHY; Kloos, RT; Mazzaferri, EL; Jhiang, SM
      Sodium iodide symporter in health and disease

      THYROID
    4. Ishiwata, K; Kobayashi, T; Kawamura, K; Matsuno, K; Senda, M
      [C-11]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [C-11]SA4503 binding was not by raclopride

      NUCLEAR MEDICINE AND BIOLOGY
    5. Robinet, EA; Wurch, T; Pauwels, PJ
      Different regulation of RGS2 mRNA by haloperidol and clozapine

      NEUROREPORT
    6. Mercier, D; Falardeau, P; Levesque, D
      Autoreceptor preference of dopamine D-2 receptor agonist correlates with preferential coupling to cyclic AMP

      NEUROREPORT
    7. Clifford, JJ; Kinsella, A; Tighe, O; Rubinstein, M; Grandy, DK; Low, MJ; Croke, DT; Waddington, JL
      Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"

      NEUROPSYCHOPHARMACOLOGY
    8. Okauchi, T; Suhara, T; Maeda, J; Kawabe, K; Obayashi, S; Suzuki, K
      Effect of endogenous dopamine on extrastriatal [C-11]FLB 457 binding measured by PET

      SYNAPSE
    9. Ohngemach, S; Feldkaemper, M; Schaeffel, F
      Pineal control of the dopamine D-2-receptor gene and dopamine release in the retina of the chicken and their possible relation to growth rhythms of the eye

      JOURNAL OF PINEAL RESEARCH
    10. Csende, F
      A simple procedure for synthesis of roxindole, a dopamine D-2-receptor agonist

      ARCHIV DER PHARMAZIE
    11. Levant, B; McCarson, KE
      D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function

      NEUROSCIENCE LETTERS
    12. Yasuno, F; Suhara, T; Sudo, Y; Yamamoto, M; Inoue, M; Okubo, Y; Suzuki, K
      Relation among dopamine D-2 receptor binding, obesity and personality in normal human subjects

      NEUROSCIENCE LETTERS
    13. Bullock, CM; Li, C; Li, M; Bermak, JC; Zhou, QY
      Sensitization of adenylate cyclase induced by a dopamine D2 receptor mutant: Inverse agonism by D2 receptor antagonists

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    14. Urbain, JLC
      Invited commentary - Reporter genes and imagene

      JOURNAL OF NUCLEAR MEDICINE
    15. Anghelescu, I; Germeyer, S; Muller, MJ; Klawe, C; Singer, P; Dahmen, N; Wetzel, H; Himmerich, H; Szegedi, A
      No association between the dopamine D-2 receptor TaqI A1 allele and earlier age of onset of alcohol dependence according to different specified criteria

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    16. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
      Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    17. Inoue, M; Suhara, T; Sudo, Y; Okubo, Y; Yasuno, F; Kishimoto, T; Yoshikawa, K; Tanada, S
      Age-related reduction of extrastriatal dopamine D-2 receptor measured by PET

      LIFE SCIENCES
    18. Kim, HJ; Koh, PO; Kang, SS; Paik, WY; Choi, WS
      The localization of dopamine D2 receptor mRNA in the human placenta and the anti-angiogenic effect of apomorphine in the chorioallantoic membrane

      LIFE SCIENCES
    19. Wilson, J; Lin, H; Fu, DY; Javitch, JA; Strange, PG
      Mechanisms of inverse agonism of antipsychotic drugs at the D-2 dopamine receptor: use of a mutant D-2 dopamine receptor that adopts the activated conformation

      JOURNAL OF NEUROCHEMISTRY
    20. Johnston, CA; Cumbay, MG; Vortherms, TA; Watts, VJ
      Adrenergic agonists induce heterologous sensitization of adenylate cyclasein NS20Y-D-2L cells

      FEBS LETTERS
    21. Sugimoto, Y; Ohkura, M; Inoue, K; Yamada, J
      Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Hasegawa, M; Adachi, K; Nakamura, S; Sato, M; Waddington, JL; Koshikawa, N
      Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D-1-like receptors in jaw movements

      EUROPEAN JOURNAL OF PHARMACOLOGY
    23. Tomiyama, K; McNamara, FN; Clifford, JJ; Kinsella, A; Koshikawa, N; Waddington, JL
      Topographical assessment and pharmacological characterization of orofacialmovements in mice: dopamine D-1-like vs. D-2-like receptor regulation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    24. Gao, X; Zhang, YQ; Wu, GC
      Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    25. Tahar, AH; Ekesbo, A; Gregoire, L; Bangassoro, E; Svensson, KA; Tedroff, J; Bedard, PJ
      Effects of acute and repeated treatment with a novel dopamine D-2 receptorligand on L-DOPA-induced dyskinesias in MPTP monkeys

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Weber, B; Schlicker, E; Sokoloff, P; Stark, H
      Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Yoshikawa, T; Yoshida, N; Oka, M
      The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist

      BRITISH JOURNAL OF PHARMACOLOGY
    28. Greba, Q; Gifkins, A; Kokkinidis, L
      Inhibition of amygdaloid dopamine D-2 receptors impairs emotional learningmeasured with fear-potentiated startle

      BRAIN RESEARCH
    29. Yasuno, F; Suhara, T; Okubo, Y; Sudo, Y; Inoue, M; Ichimiya, T; Tanada, S
      Dose relationship of limbic-cortical D-2-dopamine receptor occupancy with risperidone

      PSYCHOPHARMACOLOGY
    30. Loh, EW; Higuchi, S; Matsushita, S; Murray, R; Chen, CK; Ball, D
      Association analysis of the GABA(A) receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population

      MOLECULAR PSYCHIATRY
    31. Jalaie, M; Lipkowitz, KB
      Published force field parameters for molecular mechanics, molecular dynamics, and Monte Carlo simulations

      REVIEWS IN COMPUTATIONAL CHEMISTRY, VOL 14
    32. Samochowiec, J; Ladehoff, M; Pelz, J; Smolka, M; Schmidt, LG; Rommelspacher, H; Finckh, U
      Predominant influence of the 3 '-region of dopamine D-2 receptor gene (DRD2) on the clinical phenotype in German alcoholics

      PHARMACOGENETICS
    33. Ogawa, O; Umegaki, H; Ishiwata, K; Asai, Y; Ikari, H; Oda, K; Toyama, H; Ingram, DK; Roth, GS; Iguchi, A; Senda, M
      In vivo imaging of adenovirus-mediated over-expression of dopamine D-2 receptors in rat striatum by positron emission tomography

      NEUROREPORT
    34. Terasmaa, A; Andbjer, B; Fuxe, K; Rinken, A
      Striatal dopamine denervation decreases the GDP binding affinity in rat striatal membranes

      NEUROREPORT
    35. Oades, RD; Rao, ML; Bender, S; Sartory, G; Muller, BW
      Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D-2-receptor occupancy

      BEHAVIOURAL PHARMACOLOGY
    36. Siemiatkowski, M; Sienkiewicz-Jarosz, H; Czlonkowska, AI; Szyndler, J; Bidzinski, A; Plaznik, A
      The effects of dopamine D-2 receptor ligands on novelty-induced behavior in the rat open field test

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    37. Pinborg, LH; Videbaek, C; Knudsen, GM; Swahn, CG; Halldin, C; Friberg, L; Paulson, OB; Lassen, NA
      Dopamine D-2 receptor quantification in extrastriatal brain regions using [I-123]epidepride with bolus/infusion

      SYNAPSE
    38. Weissenborn, K; Berding, G; Kostler, H
      Altered striatal dopamine D-2 receptor density and dopamine transport in apatient with hepatic encephalopathy

      METABOLIC BRAIN DISEASE
    39. Xu, XH; Stewart, JT
      Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    40. Tahar, AH; Gregoire, L; Bangassoro, E; Bedard, PJ
      Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys

      CLINICAL NEUROPHARMACOLOGY
    41. Vilkman, H; Kajander, J; Nagren, K; Oikonen, V; Syvalahti, E; Hietala, J
      Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    42. Kusumi, I; Takahashi, Y; Suzuki, K; Kameda, K; Koyama, T
      Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D-2 and serotonin 5-HT2A receptors in the rat brain

      JOURNAL OF NEURAL TRANSMISSION
    43. Zahniser, NR; Simosky, JK; Mayfield, RD; Negri, CA; Hanania, T; Larson, GA; Kelly, MA; Grandy, DK; Rubinstein, M; Low, MJ; Fredholm, BB
      Functional uncoupling of adenosine A(2A) receptors and reduced response tocaffeine in mice lacking dopamine D-2 receptors

      JOURNAL OF NEUROSCIENCE
    44. Meisenzahl, EM; Dresel, S; Frodl, T; Schmitt, GJE; Preuss, UW; Rossmuller, B; Tatsch, K; Mager, T; Hahn, K; Moller, HJ
      D-2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study

      JOURNAL OF PSYCHOPHARMACOLOGY
    45. Huey, KA; Powell, FL
      Time-dependent changes in dopamine D-2-receptor mRNA in the arterial chemoreflex pathway with chronic hypoxia

      MOLECULAR BRAIN RESEARCH
    46. Kaasinen, V; Ruottinen, HM; Nagren, K; Lehikoinen, P; Oikonen, T; Rinne, JO
      Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone

      JOURNAL OF NUCLEAR MEDICINE
    47. Lawford, BR; Young, RM; Noble, EP; Sargent, J; Rowell, J; Shadforth, S; Zhang, XX; Ritchie, T
      The D-2 dopamine receptor al allele and opioid dependence: Association with heroin use and response to methadone treatment

      AMERICAN JOURNAL OF MEDICAL GENETICS
    48. Noble, EP; Zhang, XX; Ritchie, TL; Sparkes, RS
      Haplotypes at the DRD2 locus and severe alcoholism

      AMERICAN JOURNAL OF MEDICAL GENETICS
    49. Mihara, K; Suzuki, A; Kondo, T; Nagashima, U; Ono, S; Otani, K; Kaneko, S
      No relationship between Taq1 A polymorphism of dopamine D-2 receptor gene and extrapyramidal adverse effects of selective dopamine D-2 antagonists, bromperidol, and nemonapride in schizophrenia: A preliminary study

      AMERICAN JOURNAL OF MEDICAL GENETICS
    50. Clifford, JJ; Usiello, A; Vallone, D; Kinsella, A; Borrelli, E; Waddington, JL
      Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D-2 dopamine receptor

      NEUROPHARMACOLOGY
    51. Kunstler, U; Hohdorf, K; Regenthal, R; Seese, A; Gertz, HJ
      Reduction of handwriting area and D-2 dopamine receptor occupancy in therapy with typical and atypical neuroleptic drugs

      NERVENARZT
    52. Richelson, E; Souder, T
      Binding of antipsychotic drugs to human brain receptors - Focus on newer generation compounds

      LIFE SCIENCES
    53. Weber, K; Ohnmacht, U; Gmeiner, P
      Enantiopure 4-and 5-aminopiperidin-2-ones: Regiocontrolled synthesis and conformational characterization as bioactive beta-turn mimetics

      JOURNAL OF ORGANIC CHEMISTRY
    54. Ding, YS; Logan, J; Bermel, R; Garza, V; Rice, O; Fowler, JS; Volkow, ND
      Dopamine receptor-mediated regulation of striatal cholinergic activity: Positron emission tomography studies with norchloro[F-18]fluoroepibatidine

      JOURNAL OF NEUROCHEMISTRY
    55. Coley, C; Woodward, R; Johansson, AM; Strange, PG; Naylor, LH
      Effect of multiple serine/alanine mutations in the transmembrane spanning region V of the D-2 dopamine receptor on ligand binding

      JOURNAL OF NEUROCHEMISTRY
    56. Lahlou, S
      Blunted presser responsiveness to intravenous quinpirole in conscious, chronic spinal cord-transected rats: peripheral vs. spinal mechanisms

      EUROPEAN JOURNAL OF PHARMACOLOGY
    57. Gao, X; Zhang, YQ; Wu, GC
      Effects of dopaminergic agents on carrageenan hyperalgesia in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    58. Thompson, TL; Moore, CC; Smith, B
      Estrogen priming modulates autoreceptor-mediated potentiation of dopamine uptake

      EUROPEAN JOURNAL OF PHARMACOLOGY
    59. Prinssen, EPM; Koek, W; Kleven, MS
      Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT1A receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    60. Ahlenius, S; Ericson, E; Florvall, L; Jimenez, P; Hillegaart, V; Wijkstrom, A
      In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D-2 receptor agonists

      EUROPEAN JOURNAL OF PHARMACOLOGY
    61. Gilliland, SL; Alper, RH; Levant, B
      Pharmacology of quinpirole-stimulated [S-35]GTP gamma S binding: discrepancy with receptor binding profile

      EUROPEAN JOURNAL OF PHARMACOLOGY
    62. Boulay, D; Depoortere, R; Oblin, A; Sanger, DJ; Schoemaker, H; Perrault, G
      Haloperidol-induced catalepsy is absent in dopamine D-2 but maintained in dopamine D-3 receptor knock-out mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    63. Salmi, P; Sproat, BS; Ludwig, J; Hale, R; Avery, N; Kela, J; Wahlestedt, C
      Dopamine D-2 receptor ribozyme inhibits quinpirole-induced stereotypy in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    64. Fujita, M; Verhoeff, NPLG; Varrone, A; Zoghbi, SS; Baldwin, RM; Jatlow, PA; Anderson, GM; Seibyl, JP; Innis, RB
      Imaging extrastriatal dopamine D-2 receptor occupancy by endogenous dopamine in healthy humans

      EUROPEAN JOURNAL OF PHARMACOLOGY
    65. Sanz, AG; Hospital, S; Badia, A; Clos, MV
      Presynaptic effect of 7-OH-DPAT on evoked [H-3]-acetylcholine release in rat striatal synaptosomes

      BRAIN RESEARCH
    66. Yu, HJ; Matsubayashi, H; Amano, T; Cai, JQ; Sasa, M
      Activation by nicotine of striatal neurons receiving excitatory input fromthe substantia nigra via dopamine release

      BRAIN RESEARCH
    67. Sanz, AG; Badia, A; Clos, MV
      Role of calcium on the modulation of spontaneous acetylcholine efflux by the D-2 dopamine receptor subtype in rat striatal synaptosomes

      BRAIN RESEARCH
    68. Gonzalez, AM; Berciano, J; Figols, J; Pazos, A; Pascual, J
      Loss of dopamine uptake sites and dopamine D-2 receptors in striatonigral degeneration

      BRAIN RESEARCH
    69. Ruzich, M; Martin-Iverson, MT
      Pinealectomy blocks stress-induced motor stimulation but not sensitizationand tolerance to a dopamine D-2 receptor agonist

      PSYCHOPHARMACOLOGY
    70. Risinger, FO; Freeman, PA; Rubinstein, M; Low, MJ; Grandy, DK
      Lack of operant ethanol self-administration in dopamine D-2 receptor knockout mice

      PSYCHOPHARMACOLOGY
    71. Silvestri, S; Seaman, MV; Negrete, JC; Houle, S; Shammi, CM; Remington, GJ; Kapur, S; Zipursky, RB; Wilson, AA; Christensen, BK; Seeman, P
      Increased dopamine D-2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

      PSYCHOPHARMACOLOGY
    72. Martin-Iverson, MT; Else, D
      PHNO, a selective dopamine D-2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats

      PSYCHOPHARMACOLOGY
    73. Kittner, H; Krugel, U; Hoffmann, E; Illes, P
      Effects of intra-accumbens injection of 2-methylthio ATP: a combined open field and electroencephalographic study in rats

      PSYCHOPHARMACOLOGY
    74. Mihara, K; Kondo, T; Suzuki, A; Yasui, N; Nagashima, U; Ono, S; Otani, K; Kaneko, S
      Prolactin response to nemonapride, a selective antagonist for D-2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene

      PSYCHOPHARMACOLOGY
    75. Shi, BZ; Narayanan, TK; Yang, ZY; Christian, BT; Mukherjee, J
      Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1 '-C-11-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors

      NUCLEAR MEDICINE AND BIOLOGY
    76. Ishiwata, K; Senda, M
      In vivo binding of [C-11]nemonapride to sigma receptors in the cortex and cerebellum

      NUCLEAR MEDICINE AND BIOLOGY
    77. Pohjalainen, T; Nagren, K; Syvalahti, EKG; Hietala, J
      The dopamine D-2 receptor 5 '-flanking variant, C-141 Ins/Del, is not associated with reduced dopamine D-2 receptor density in vivo

      PHARMACOGENETICS
    78. Rinken, A; Ferre, S; Terasmaa, A; Owman, C; Fuxe, K
      Serotonergic agonists behave as partial agonists at the dopamine D-2 receptor

      NEUROREPORT
    79. Kasper, S; Tauscher, J; Kufferle, B; Barnas, C; Pezawas, L; Quiner, S
      Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    80. Raedler, TJ; Knable, MB; Lafargue, T; Urbina, RA; Egan, MF; Pickar, D; Weinberger, DR
      In vivo determination of striatal dopamine D-2 receptor occupancy in patients treated with olanzapine

      PSYCHIATRY RESEARCH-NEUROIMAGING
    81. Tallerico, T; Ulpian, C; Liu, ISC
      Dopamine D-2 receptor promoter polymorphism: no association with schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    82. Ishiwata, K; Hayakawa, N; Ogi, N; Oda, K; Toyama, H; Endo, K; Tanaka, A; Senda, M
      Comparison of three PET dopamine D-2-like receptor ligands, [C-11]raclopride, [C-11]nemonapride and [C-11]N-methylspiperone, in rats

      ANNALS OF NUCLEAR MEDICINE
    83. Ishiwata, K; Ishii, S; Senda, M
      An alternative synthesis of [C-11]raclopride for routine use

      ANNALS OF NUCLEAR MEDICINE
    84. GUREVICH EV; JOYCE JN
      DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS

      Neuropsychopharmacology
    85. Tremblay, M; Rouillard, C; Levesque, D
      Dopamine D-3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain

      SYNAPSE
    86. Langer, O; Nagren, K; Dolle, F; Lundkvist, C; Sandell, J; Swahn, CG; Vaufrey, F; Crouzel, C; Maziere, B; Halldin, C
      Precursor synthesis and radiolabelling of the dopamine D-2 receptor ligand[C-11]raclopride from [C-11]methyl triflate

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    87. Booij, J; Tissingh, G; Winogrodzka, A; van Royen, EA
      Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    88. STEINER H; GERFEN CR
      ENKEPHALIN REGULATES ACUTE D-2 DOPAMINE-RECEPTOR ANTAGONIST-INDUCED IMMEDIATE-EARLY GENE-EXPRESSION IN STRIATAL NEURONS

      Neuroscience
    89. Yamamoto, Y; Nakanishi, H; Takai, N; Shimazoe, T; Watanabe, S; Kita, H
      Expression of N-methyl-D-aspartate receptor-dependent long-term potentiation in the neostriatal neurons in an in vitro slice after ethanol withdrawalof the rat

      NEUROSCIENCE
    90. Hesselink, MB; De Boer, AG; Breimer, DD; Danysz, W
      Adaptations of NMDA and dopamine D-2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists

      JOURNAL OF NEURAL TRANSMISSION
    91. Darmani, NA; Zhao, W; Ahmad, B
      The role of D-2 and D-3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)

      JOURNAL OF NEURAL TRANSMISSION
    92. Obadiah, J; Avidor-Reiss, T; Fishburn, CS; Carmon, S; Bayewitch, M; Vogel, Z; Fuchs, S; Levavi-Sivan, B
      Adenylyl cyclase interaction with the D2 dopamine receptor family; Differential coupling to Gi, Gz, and Gs

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    93. Hietala, J; Nagren, K; Lehikoinen, P; Ruotsalainen, U; Syvalahti, E
      Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    94. Tallerico, T; Ulpian, C; Liu, ISC
      Dopamine D-2 receptor promoter polymorphism: no association with schizophrenia

      PSYCHIATRY RESEARCH
    95. Hoberg, E; Orjala, J; Meier, B; Sticher, O
      Diterpenoids from the fruits of Vitex agnus-castus

      PHYTOCHEMISTRY
    96. Araki, H; Hino, N; Karasawa, Y; Kawasaki, H; Gomita, Y
      Effect of dopamine blockers on cerebral ischemia-induced hyperactivity in gerbils

      PHYSIOLOGY & BEHAVIOR
    97. Boulay, D; Depoortere, R; Perrault, G; Borrelli, E; Sanger, DJ
      Dopamine D-2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D-2/D-3 receptor agonists

      NEUROPHARMACOLOGY
    98. Oliveri, RL; Annesi, G; Zappia, M; Civitelli, D; Montesanti, R; Branca, D; Nicoletti, G; Spadafora, P; Pasqua, AA; Cittadella, R; Andreoli, V; Gambardella, A; Aguglia, U; Quattrone, A
      Dopamine D-2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD

      NEUROLOGY
    99. Filteau, F; Veilleux, F; Levesque, D
      Effects of reciprocal chimeras between the C-terminal portion of third intracellular loops of the human dopamine D-2 and D-3 receptors

      FEBS LETTERS
    100. Domino, EF; Ni, LS; Zhang, HL
      Nicotine alone and in combination with L-DOPA methyl ester or the D-2 agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys

      EXPERIMENTAL NEUROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 14:58:12